Cambridge Research Biochemicals and Key Organics announce global supply agreement

Cambridge Research Biochemicals (CRB) and Key have entered into an  exclusive supply & marketing agreement that makes CRB’s peptides available to Key Organics’ customers base through its online catalogue.

Emily Humphrys, commercial director at CRB commented: “Our partnership with Key Organics will allow us to expand the reach of our growing peptide product portfolio to a global market. We will continue to focus on our core peptide activities, serving our key customers with bespoke custom-made peptides, whilst Key Organics sells our new catalogue peptide range.”

Joe Carey, managing director at Key Organics added: “We have been seeking to extend our product range in the peptide area so are delighted to enter into this agreement with CRB. The company has established itself as a world leader in peptide chemistry with an excellent quality and service record that conforms to the standards we have established for our BIONET portfolio."

CRB was established in 1980 and is a key player in the supply of custom–made peptides. It has recently expanded its premises in Billingham, UK. CRB continues to develop the range of products and services offered and can supply all flavours of peptides.

Key Organics offers over 74,000 screening compounds, intermediates, building blocks and biochemicals to the international pharmaceutical, biotechnology and agrochemical industries.